Abiopharma

Resmed to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference

Mulvihill Canadian Bank Enhanced Yield ETF Announces Semi-Annual Results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS

Kornfeld Steven 🔴 sold 60.3K shares (8 derivative) of Forte Biosciences, Inc. (FBRX) at $888.50 ($1.6M) Transaction Date: Aug 27, 2026 | Filing ID: 000003

PNR Investors Have Opportunity to Lead Pentair plc Securities Fraud Lawsuit

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS

Brun Scott C. 🔴 sold 54.4K shares (5 derivative) of Forte Biosciences, Inc. (FBRX) at $25.00 Transaction Date: Aug 27, 2026 | Filing ID: 000003

Narayanadas Vivek 🔴 sold 223 shares of Oklo Inc. (OKLO) at $40.80 Transaction Date: Aug 25, 2026 | Filing ID: 000006

ROTHBLATT MARTINE A 🟡 adjusted position in 9.5K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $521.48 ($7.5M) Transaction Date: Aug 26, 2026 | Filing ID: 000129

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO

Affirm reports fourth fiscal quarter 2026 results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION

Pfizer Inc. - Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Kapoor Shivpreet Singh 🔴 sold 51.4K shares (3 derivative) of Forte Biosciences, Inc. (FBRX) at $7.54 Transaction Date: Aug 27, 2026 | Filing ID: 000003